Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Acute Stroke Outcome
NCT06107725Phase 3Terminated
- Sponsor
- Maimonides Medical Center
- Start
- Nov 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in stroke, sponsored by Maimonides Medical Center. Started Nov 2023; status: terminated.
02
Drugs
minocycline
03
Conditions
stroke
Beyond the preview
Go deeper on NCT06107725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06107725.